title: NCCN task force: clinical utility of PET in a variety of tumor types.
abstract: Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.
authors: The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
authors: Donald A
authors: DA
authors: Podoloff
authors: Douglas W
authors: DW
authors: Ball
authors: Edgar
authors: E
authors: Ben-Josef
authors: Al B
authors: AB
authors: Benson
authors: Steven J
authors: SJ
authors: Cohen
authors: R Edward
authors: RE
authors: Coleman
authors: Dominique
authors: D
authors: Delbeke
authors: Maria
authors: M
authors: Ho
authors: David H
authors: DH
authors: Ilson
authors: Gregory P
authors: GP
authors: Kalemkerian
authors: Richard J
authors: RJ
authors: Lee
authors: Jay S
authors: JS
authors: Loeffler
authors: Homer A
authors: HA
authors: Macapinlac
authors: Robert J
authors: RJ
authors: Morgan
authors: Barry Alan
authors: BA
authors: Siegel
authors: Seema
authors: S
authors: Singhal
authors: Douglas S
authors: DS
authors: Tyler
authors: Richard J
authors: RJ
authors: Wong
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D009369:Neoplasms / Q000145:classification / Q000000981:diagnostic imaging* / Q000628:therapy; D049268:Positron-Emission Tomography / Q000706:statistics & numerical data*; D011379:Prognosis; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18